Whether nitrofurazone-impregnated catheters have a clinically important impact on the risk of UTI compared to standard catheters is uncertain, but they may be cost-effective for the NHS
- Faculty of Health Sciences, University of Southampton, Southampton, Hampshire, UK
- Correspondence to: Dr Jacqui Prieto
Faculty of Health Sciences, University of Southampton, Level A, South Academic Block (MP 11), Southampton General Hospital, Tremona Road, Southampton, Hampshire SO16 6YD, UK;
Commentary on: Pickard R, Lam T, Maclennan G, et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: a multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial). Health Technol Assess 2012;16:1–197.
Implications for practice and research
This study provides evidence that antimicrobial urethral catheters may not benefit patients admitted to hospital for elective surgery and therefore standard catheters are recommended.
Further research is needed to determine whether antimicrobial urethral catheters would benefit patients hospitalised for medical or critical care reasons.
Around 25% of the hospitalised patients undergo short-term indwelling catheterisation,1 which accounts for up to 80% of healthcare-associated urinary tract infection (UTI).2 The incidence of bacteriuria (bacterial contamination of urine) among catheterised patients is approximately 5% per day1 and infection is estimated to develop in one quarter of patients with bacteriuria.1 …